Citation: Mc. Leavitt et al., Inhibition of interleukin-1 beta (IL-1 beta) production in human cells by ribozymes against IL-1 beta and IL-1 beta converting enzyme (ICE), ANTISENSE N, 10(6), 2000, pp. 409-414
Citation: Y. Chen et al., In vivo expression of single-stranded DNA in mammalian cells with DNA enzyme sequences targeted to C-raf, ANTISENSE N, 10(6), 2000, pp. 415-422
Citation: M. Nesterova et Ys. Cho-chung, Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RI alpha subunit, ANTISENSE N, 10(6), 2000, pp. 423-433
Authors:
Leeds, JM
Henry, SP
Geary, R
Burckin, T
Levin, AA
Citation: Jm. Leeds et al., Comparison of the pharmacokinetics of subcutaneous and intravenous administration of a phosphorothioate oligodeoxynucleotide in cynomolgus monkeys, ANTISENSE N, 10(6), 2000, pp. 435-441
Authors:
Sedelnikova, OA
Panyutin, IG
Luu, AN
Reed, MW
Licht, T
Gottesman, MM
Neumann, RD
Citation: Oa. Sedelnikova et al., Targeting the human mdr1 gene by I-125-labeled triplex-forming oligonucleotides, ANTISENSE N, 10(6), 2000, pp. 443-452
Authors:
Miraglia, L
Watt, AT
Graham, MJ
Crooke, ST
Citation: L. Miraglia et al., Variations in mRNA content have no effect on the potency of antisense oligonucleotides, ANTISENSE N, 10(6), 2000, pp. 453-461
Authors:
Malchere, C
Verheijen, J
Van der Laan, S
Bastide, L
Van Boom, J
Lebleu, B
Robbins, I
Citation: C. Malchere et al., A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid, ANTISENSE N, 10(6), 2000, pp. 463-468
Authors:
Epa, WR
Greferath, U
Shafton, A
Rong, P
Delbridge, LM
Bennie, A
Barrett, GL
Citation: Wr. Epa et al., Downregulation of the p75 neurotrophin receptor in tissue culture and in vivo, using beta-cyclodextrin-adamantane-oligonucleotide conjugates, ANTISENSE N, 10(6), 2000, pp. 469-478
Citation: B. Wiesenhofer et al., Glial cell line-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: evidence from antisense experiments, ANTISENSE N, 10(5), 2000, pp. 311-321
Authors:
Cairns, MJ
Hopkins, TM
Witherington, C
Sun, LQ
Citation: Mj. Cairns et al., The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzyme, ANTISENSE N, 10(5), 2000, pp. 323-332
Citation: M. Rusckowski et al., Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose administration in mice, ANTISENSE N, 10(5), 2000, pp. 333-345
Authors:
Karras, JG
McKay, RA
Lu, T
Dean, NM
Monia, BP
Citation: Jg. Karras et al., Antisense inhibition of membrane-bound human interleukin-5 receptor-alpha chain does not affect soluble receptor expression and induces apoptosis in TF-1 cells, ANTISENSE N, 10(5), 2000, pp. 347-357
Authors:
Templin, MV
Levin, AA
Graham, MJ
Aberg, PM
Axelsson, BI
Butler, M
Geary, RS
Bennett, CF
Citation: Mv. Templin et al., Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotidefollowing inhalation delivery to lung in mice, ANTISENSE N, 10(5), 2000, pp. 359-368
Authors:
Cao, A
Briane, D
Coudert, R
Vassy, J
Lievre, N
Olsman, E
Tamboise, E
Salzmann, JL
Rigaut, JP
Taillandier, E
Citation: A. Cao et al., Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomesderived from cholesterol, ANTISENSE N, 10(5), 2000, pp. 369-380
Citation: Hm. Zhao et al., Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs, ANTISENSE N, 10(5), 2000, pp. 381-389
Authors:
Dittmar, T
Schafer, F
Brandt, BH
Zanker, KS
Citation: T. Dittmar et al., Accelerated assessing of antisense RNA efficacy using a chimeric enhanced green fluorescent protein-antisense RNA-producing vector, ANTISENSE N, 10(5), 2000, pp. 401-408
Authors:
Hoque, ATMS
Sedelnikova, OA
Luu, AN
Swaim, WD
Panyutin, IG
Baum, BJ
Citation: Atms. Hoque et al., Use of polyethylenimine-adenovirus complexes to examine tripler formation in intact cells, ANTISENSE N, 10(4), 2000, pp. 229-241
Authors:
Akie, K
Dosaka-Akita, H
Murakami, A
Kawakami, Y
Citation: K. Akie et al., A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer, ANTISENSE N, 10(4), 2000, pp. 243-249
Citation: L. Cagnon et Jj. Rossi, Downregulation of the CCRS beta-chemokine receptor and inhibition of HIV-1infection by stable VA1-ribozyme chimeric transcripts, ANTISENSE N, 10(4), 2000, pp. 251-261
Citation: C. Ghosh et Pl. Iversen, Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers, ANTISENSE N, 10(4), 2000, pp. 263-274
Citation: Y. Liao et Br. Duling, Blockade of connexin 43 expression by stable transfection of antisense cDNA in cultured vascular smooth muscle cells, ANTISENSE N, 10(4), 2000, pp. 275-281
Authors:
Cogoi, S
Suraci, C
Del Terra, E
Diviacco, S
Van der Marel, G
Van Boom, J
Quadrifoglio, F
Xodo, L
Citation: S. Cogoi et al., Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells, ANTISENSE N, 10(4), 2000, pp. 283-295
Citation: M. Shahabuddin et As. Khan, Inhibition of human immunodeficiency virus type 1 by packageable, multigenic antisense RNA, ANTISENSE N, 10(3), 2000, pp. 141-151